U.S. Stocks in Motion | Medical technology company Davion Healthcare Plc (DAVI.US) debuts on the U.S. stock market, with its share price falling more than 12% after the opening.

Zhitong Finance APP has learned that on Thursday, Davion Healthcare Plc (DAVI.US) debuted in the U.S. stock market, with its share price falling more than 12% after the opening to $10.73. The IPO price was $12.25. Davion Healthcare Plc is an Ireland-based medical technology company focused on the research, development, and commercialization of non-invasive home health monitoring technology, aiming to help consumers detect potential health abnormalities early. The company's flagship product, BreastCheck, is an FDA-registered home breast health screening product that can identify potential abnormalities by monitoring changes in breast surface temperature. The detection process takes less than 15 minutes, and results can be viewed through a mobile app or online. However, it cannot replace mammography or clinical diagnosis.